isbscience.org/news/2014/09/29/xconomy-com-features-100k-project/
Xconomy featured an article about the 100K Wellness Project. The article provides an introduction and follows with a Q&A with Dr. Nathan Price, who is Associate Director of ISB.
Read the article by Alex Lash, Xconomy.com’s National Biotech Editor: “100K” Marathon: A Decades-Long Health Study Makes Its Business Case
ISB Associate Professor Dr. Sean Gibbons was named a Highly Cited Researcher for 2023. It is the second consecutive year Gibbons has earned the distinction. The Highly Cited Research list is generated annually by Clarivate, which says: “Of the world’s population of scientists and social scientists, Highly Cited Researchers are 1 in 1,000.”
Each month throughout the 2023-2024 academic year, we will highlight some of the top projects the ISB Education team is working on.
In a breakthrough discovery that changes how we understand T cells and with implications of how we can better engineer custom immune responses to fight disease, Institute for Systems Biology researchers showed that the different disease-fighting functions of different T cells are determined by the genetically encoded T-cell receptor sequence that are unique to those cells.
